Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.5000
+0.1100 (4.60%)
NASDAQ· Last Trade: Aug 24th, 7:25 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors